1575 - Autologous fat grafting (AFG) by injection, for defects arising from breast surgery, cancer treatment/prevention or congenital deformity

Page last updated: 12 October 2020

Application Detail

Description of Medical Service

Fat grafting is currently used for the management of breast cancer patients, but there is no MBS item number, so its use is often coded as “scar-revision”. Autologous fat grafting (AFG) is the harvesting, preparation and re-injection of autologous fat, with or without specialised fat grafting equipment. It includes live fat cells being harvested from a donor site on the patient, prepared in theatre by a variety of methods to separate and purify the fat cells, and injected back into the defective area. It relies on the fat stem cells remaining viable in the transferred site. Fat transfer, or fat grafting, or lipo-filling, or lipo-modelling, allows wider use of prosthetic breast reconstruction and can avoid the need for autologous reconstruction. It can minimise the need for extensive revisional surgery for defects after breast reconstruction..

Description of Medical Condition

AFG (proposed service) is used for defects arising from the following medical conditions: breast reconstruction surgery after breast cancer excision and/or mastectomy for cancer or cancer risk reduction; and surgery for developmental breast disorders.

Reason for Application

New MBS item

Medical Service Type


Previous Application Number

Not Applicable

Associated Documentation

Application Form

Application Form (PDF 1394 KB)
Application Form (Word 348 KB)

Consultation Survey

Consultation Survey (PDF 559 KB)
Consultation Survey (Word 67 KB)

PICO Confirmation

PICO Confirmation (PDF 1229 KB)
PICO Confirmation (Word 242 KB)

Assessment Report


Public Summary Document

Public Summary Document (PDF 1472 KB)
Public Summary Document (Word 229 KB)

Meetings for this Application


11 April 2019


12 June 2020


28-29 July 2020